A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3
スポンサーリンク
概要
著者
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Komatsu Hirokazu
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
Iida S
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Iida Shinsuke
名古屋市立大学 医学研究科腫瘍免疫内科学
-
Iida Shinsuke
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Nitta Masakazu
Department Of Internal Medicine Division Of Hematology Aichi Medical University School Of Medicine
-
Nitta Masakazu
愛知医科大学 医学部血液内科
-
Nitta M
Aichi Medical Univ. Aichi
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Miwa Hiroshi
愛知医科大学 医学部血液内科
-
Kano Hideyuki
Department Of Bioscience School Of Science And Graduate School Of Fundamental Life Science Kitasato
-
Yamamoto Masahiko
Department Of Pediatrics Nagoya City University Medical School
-
Maeda Hiroyoshi
Division Of Hematology Department Of Internal Medicine Aichi Medical University
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Komatsu Hirokazu
Second Department Of Internal Medicine Nagoya City University School Of Medicine
-
Iida Shinsuke
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
TAKEUCHI Genji
Division of Hematology, Shizuoka Saiseikai General Hospital
-
Yamamoto Masahiko
Mie University Graduate School Of Medicine
-
Iino S
Department Of Medicine Seizankai Kiyokawa Hospital
-
IWAKI Osamu
Division of Hematology and Rheumatology, Shizuoka Saiseikai General Hospital
-
Maeda Hiroyoshi
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Nitta Masakazu
Second Department Of Medicine Nagoya City University Medical School
-
Iwaki Osamu
Division Of Hematology And Rheumatology Shizuoka Saiseikai General Hospital
-
Tsuboi Kazuya
Second Department Of Internal Medicine Nagoya City University Medical School
-
Takeuchi Genji
Division Of Hematology Shizuoka Saiseikai General Hospital
-
Wakita A
Nagoya City Univ. Graduate School Of Medical Sci. Nagoya Jpn
-
Takada Katsutoshi
Clinical Molecular Informative Medicine Nagoya City University Graduate School Of Medical Sciences
-
Iino Shiro
Department Of Medicine Seizankai Kiyokawa Hospital
-
Kuroda Hiroyuki
Laboratory Of Chemotherapy Aichi Cancer Center Research Institute
-
Banno Shogo
Second Department Of Internal Medicine Medical School Nagoya City University
-
Miwa Hiroshi
Second Department Of Internal Medicine Aichi Medical University
-
Koike Koichi
Department Of Hematology Aomori Prefectural Central Hospital
関連論文
- Rapid analysis of Clostridium difficile strains recovered from hospitalized patients by using the slpA sequence typing system
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma : two case reports
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
- Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3
- Clinical Aspects of Multimodality Therapy for Resectable Locoregional Esophageal Cancer
- Physical exercise reduces risk of breast cancer in Japanese women
- A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load
- Spontaneous Cure of Chronic Hepatitis B with Hapatocellular Carcinoma and Concomitant HBsAg Reappearance and Disappearance
- Atypical Serous Cystadenoma of the Pancreas with Suspected Malignant Potential : Report of a Case and Review of the Literature
- Hepatitis B virus genotype G is an extremely rare genotype in Japan
- A Phase II Study of S-1 in Patients with Metastatic Breast Cancer : A Japanese Trial by the S-1 Cooperative Study Group, Breast Cancer Working Group
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Early Detection of Plasma Cytomegalovirus DNA by Real-Time PCR after Allogeneic Hematopoietic Stem Cell Transplantation
- Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
- Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Expression of the TCL1 Gene at 14q32 in B-Cell Malignancies but Not in Adult T-Cell Leukemia
- Novel processing techniques of pH and heat stable chitosan nano-particles
- Serotype-Specific Modulation of Human Monocyte Functions by Glycopeptidolipid (GPL) Isolated from Mycobacterium avium Complex(Miscellaneous)
- T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia
- Lack of Ku80 Alteration in Multiple Myeloma
- Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy
- Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Improvement of Splenomegaly and Pancytopenia by Enzyme Replacement Therapy Against Type 1 Gaucher Disease: A Report of Sibling Cases
- Multiple myeloma preceding the development of chronic myelogenous leukemia
- Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas
- Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection
- Results of patch testing with 1, 3-butylene glycol from 1994 to 1999
- The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma
- Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
- Latex protein induced delayed-type contact allergy
- A case of contact dermatitis due to water-soluble licorice extract
- A case of contact dermatitis due to glycol salicylate
- The study on the role of Myocoptes musculinus (kekuidani) on the skin eruptions of the atopic model mice (NC mice)
- Effect of zinc oxide ointment containing nonanoic acid vanillylamide (ZONVA) on the skin eruptions of atopic model mice (NC/F mice)
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Some components of adipic polyesters induce allergic contact dermatitis
- Study about the stinging sensation due to a tacrolimus ointment on atopic dermatitis patients
- Five cases of latex allergy from 1998 to 2000
- Three cases of lip dermatitis due to diisostearyl malate
- Photocontact dermatitis due to ketoprofen ; possible mechanism of photocontact allergy and the photocross-reactivity to suprofen, tiaprofenic acid
- Di(2-ethylhexyl) phthalate (DOP) in a vinyl-chloride slip-guard of cotton gloves caused contact urticaria syndrome
- Safety evaluation of hypo-irritant products containing 0.005% nonanoic acid vanillylamide (NVA) on the patients with skin diseases
- Clinical evaluation of hypo-irritant products containing 0.005% nonanoic acid vanillylamide (NVA) on the itching sensation of the patients under dialysis
- A questionnaire study on the dialysis patients
- Study on the skin function of dialysis patients
- Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Profile of Participants and Genotype Distributions of 108 Polymorphisms in a Cross-Sectional Study of Associations of Genotypes With Lifestyle and Clinical Factors : A Project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study